JT ahead on points in that round. Love your work JT, you can stay.
Perhaps a reread of Q2 in the ASX aware letter is in order.
A couple of points I haven't posted b4:
The patients were new to ART, it was never said that they were new infections.
Biotron have already conclusively proven that 225 reduces VL on its own.
Make of that what you will but you might have to remove the shadow roll, as well as the blinkers.
Oh.... MM confirmed again at the AGM that it was a placebo controlled study. Let's not get petty with words huh, there WAS a placebo.
